DURECT Corp (NASDAQ:DRRX)
CAPS Rating:
The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.
RSS Headlines
Fool UK
Recs
Back to it's 52 week high of 6.4 on the news. Fell short today, but it will still have legs.